125P Response assessment of metastatic uveal melanoma treated with rose bengal disodium

ConclusionImaging response assessment of pts treated with PV-10 using RECIST may lead to premature and inaccurate determination of progression. 2D-EASL provides information specific to the behavior of injected lesions. Immunotherapy-centric criteria (irRC, irRECIST and iRECIST) could be a useful alternative to 2D-EASL.Clinical trial identificationNCT00986661.Legal entity responsible for the studyProvectus Biopharmaceuticals.FundingProvectus Biopharmaceuticals.DisclosureE.A. Wachter: Full / Part-time employment: Provectus Biopharmaceuticals. All other authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research